Cargando…

Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Lei, Hong, Alu, Aqu, Yang, Jingyun, He, Cai, Hong, Weiqi, Cheng, Zesheng, Yang, Li, Li, Jiong, Wang, Zhenling, Wang, Wei, Lu, Guangwen, Wei, Xiawei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729145/ https://www.ncbi.nlm.nih.gov/pubmed/33311439 http://dx.doi.org/10.1038/s41392-020-00434-x

Ejemplares similares

Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants
por: Lei, Hong, et al.
Publicado: (2022)

Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants
por: Lei, Hong, et al.
Publicado: (2023)

A recombinant spike‐XBB.1.5 protein vaccine induces broad‐spectrum immune responses against XBB.1.5‐included Omicron variants of SARS‐CoV‐2
por: He, Cai, et al.
Publicado: (2023)

Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection
por: Yang, Jingyun, et al.
Publicado: (2023)

A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS‐CoV‐2 variants and wild‐type of the virus
por: He, Cai, et al.
Publicado: (2021)

Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5‐included SARS‐CoV‐2 variants than homologous vaccination of mRNA vaccine
por: Peng, Dandan, et al.
Publicado: (2023)

Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19
por: Ni, Yanghong, et al.
Publicado: (2021)

BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies
por: Alu, Aqu, et al.
Publicado: (2022)

Intranasal COVID-19 vaccines: From bench to bed
por: Alu, Aqu, et al.
Publicado: (2022)

cGAS-STING pathway in cancer biotherapy
por: Wang, Yang, et al.
Publicado: (2020)

The modulatory effect of high salt on immune cells and related diseases
por: Li, Xian, et al.
Publicado: (2022)

Spike protein of SARS‐CoV‐2 Omicron (B.1.1.529) variant has a reduced ability to induce the immune response
por: He, Cai, et al.
Publicado: (2022)

S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis
por: Ye, Fei, et al.
Publicado: (2021)

Trimeric protein vaccine based on Beta variant elicits robust immune response against BA.4/5-included SARS-CoV-2 Omicron variants
por: He, Cai, et al.
Publicado: (2023)

The role of lysosome in regulated necrosis
por: Alu, Aqu, et al.
Publicado: (2020)

Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy
por: Han, Xuejiao, et al.
Publicado: (2022)

Cationic nanocarriers induce cell necrosis through impairment of Na(+)/K(+)-ATPase and cause subsequent inflammatory response
por: Wei, Xiawei, et al.
Publicado: (2015)

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant
por: He, Cai, et al.
Publicado: (2022)

Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment
por: Que, Haiying, et al.
Publicado: (2022)

SARS‐CoV‐2 Omicron variant: Characteristics and prevention
por: He, Xuemei, et al.
Publicado: (2021)

Elicitation of potent neutralizing antibodies in obese mice by ISA 51-adjuvanted SARS-CoV-2 spike RBD-Fc vaccine
por: Li, Chia-Jung, et al.
Publicado: (2023)

Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanorings
por: Gungor, Bilgi, et al.
Publicado: (2014)

Targeted therapy for head and neck cancer: signaling pathways and clinical studies
por: Li, Qingfang, et al.
Publicado: (2023)

Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells
por: Hong, Weiqi, et al.
Publicado: (2022)

Hyperprogression: A novel response pattern under immunotherapy
por: Han, Xue‐jiao, et al.
Publicado: (2020)

An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery
por: Petkar, Kailash C., et al.
Publicado: (2021)

Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery
por: Yu, Xiaolin, et al.
Publicado: (2021)

A mouse model for SARS-CoV-2-induced acute respiratory distress syndrome
por: Hong, Weiqi, et al.
Publicado: (2021)

Cholesterol-modified Hydroxychloroquine-loaded Nanocarriers in Bleomycin-induced Pulmonary Fibrosis
por: Liu, Li, et al.
Publicado: (2017)

The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
por: Huang, Yuhe, et al.
Publicado: (2022)

Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD
por: Ma, Hang, et al.
Publicado: (2022)

Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2-transgenic mice
por: Bi, Zhenfei, et al.
Publicado: (2021)

Scientific rationale for developing potent RBD-based vaccines targeting COVID-19
por: Kleanthous, Harry, et al.
Publicado: (2021)

SARS-CoV-2 tetrameric RBD protein blocks viral infection and induces potent neutralizing antibody response
por: Liu, Zheng, et al.
Publicado: (2022)

Manganese salts function as potent adjuvants
por: Zhang, Rui, et al.
Publicado: (2021)

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
por: Junker, Daniel, et al.
Publicado: (2022)

Bio-Mediated Synthesis and Characterisation of Silver Nanocarrier, and Its Potent Anticancer Action
por: Lee, Kar Xin, et al.
Publicado: (2019)

Moxifloxacin and Sulfamethoxazole-Based Nanocarriers Exhibit Potent Antibacterial Activities
por: Akbar, Noor, et al.
Publicado: (2021)

Tuning the Immunostimulation Properties of Cationic Lipid Nanocarriers for Nucleic Acid Delivery
por: Dey, Arindam K., et al.
Publicado: (2021)

Delivery of the Radionuclide (131)I Using Cationic Fusogenic Liposomes as Nanocarriers
por: Kolašinac, Rejhana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oep0mttbd1bah6ceehk1ri7plm